NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » Pfizer back to previous page show list

Pfizer

»
address: Pfizer Limited
European Hdqtrs for R & D
Ramsgate Road
Sandwich
Kent
CT13 9NJ
contact: www.pfizer.co.uk

trunover in millions USD: 45100
R & D turnover in millions USD: 7599
NET profit: 19337
year of financial results: 2006
employees: 122

active in China: YES

SFDA approved: NO

Approvals:
GLP: YES
GMP: NO
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: NO
Ingredients: NO
Western Generics: NO
TCM: NO

R & D:
Discovery: NO
Work Up (pilot to production): NO
Analysis: NO
Quality Control: NO
Stability: NO
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: NO
Support Labs: YES

Non clinical & preclinical:
Animal Testing: GLP: NO
New materials Safety Assessment: YES
Pharmaceuticals: NO
Agrochemicals: YES
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: NO

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 

Pfizer Inc, founded in 1849, is dedicated to better health and greater access to healthcare for people and their valued animals. Our purpose is helping people live longer, healthier, happier lives. Our route to that purpose is through discovering and developing breakthrough medicines; providing information on prevention, wellness, and treatment; consistent high-quality manufacturing of medicines, consumer products; and global leadership in corporate responsibility. Every day we help 38 million patients, employ more than 122,000 colleagues, utilize the skills of more than 12,000 medical researchers, and work in partnership with governments, individuals, and other payers for healthcare to treat and prevent illnesses—adding both years to life, and life to years.

Pfizer in China

In the 1980's, following in tow with the progress of China's opening and reform, Pfizer entered the China market with a long term vision for development. Pfizer now has three business segments in China: pharmaceutical, capsule and animal health products.

Pfizer is committed to the long-term development of China's healthcare environment and strives to improve Chinese healthcare through continuing to introduce, manufacture and market many of our leading innovative medications. We are distinctive in our pursuit to make these available to Chinese patients at the same time of their introductions globally. With an unequalled product portfolio, Pfizer China maintains category leadership in the therapeutic areas of cardiovascular disease, endocrinology, neuroscience, arthritis and other inflammatory diseases, infectious disease, urology, ophthalmology and oncology. The depth of our reach has enabled us to hold the highest percentage of market share of any foreign pharmaceutical company in China.

With the support of various levels of the Chinese government and the public sectors, Pfizer's operations in China have developed rapidly. With an investment of more than US$500 million, Pfizer is one of the largest foreign pharmaceutical enterprises in China. Pfizer successfully established state-of-the-art plants in Dalian, Suzhou and Wuxi. The Dalian plant was the first in China to receive GMP certification. As part of a globally integrated Pfizer Global Manufacturing organization, we are committed to making "Quality" one of our core values and to producing products that fit our values. Meanwhile, we continue to pursue innovation, improve product costs, and maintain the industry's highest environmental, health and safety standards. Pfizer's success in China has solidified our faith in the achievability of the long-term development of China's healthcare environment. Pfizer opened many branch offices in most major cities throughout China. In 1997, Pfizer established its China management center in Beijing; in 2004, established the Pfizer Investment Co.,Ltd. and the Pfizer China Regional Headquarters in Shanghai to integrate and oversee all of Pfizer's China operations. These milestones have made China a priority in Pfizer's global strategy. In the coming five years, Pfizer plans to introduce 15 innovative products in the China market, three times the number of products launched in the past five years. This will further serve to benefit Chinese patients and contribute significantly to all of society.


company map(s):

company map(s): Pfizer company map(s): Pfizer company map(s): Pfizer

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.